final program

 

Saturday,
July 28, 2012
Sunday,
July 29, 2012
Monday,
July 30, 2012
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Sunday, July 29, 2012

08:30-10:45   HALL A
 

PL07    Plenary Session:
CURRENT CONCEPTS AND FUTURE DIRECTIONS IN ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROME
 

Chairs:
J.H. Chesebro, Worcester, MA, USA
U. Thadani, Oklahoma City, OK, USA

 
08:30 CAN VULNERABLE PLAQUE BE IDENTIFIED AND TREATED TO PREVENT FUTURE ADVERSE CV EVENTS? (Invited Lecture)
J. Ambrose, UCSF, Fresno, CA, USA
181
08:45 WHAT IS CONSIDERED TO BE THE OPTIMAL TREATMENT FOR STABLE ANGINA IN THE YEAR 2012? (Invited Lecture)
U. Thadani, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA
 
182
09:00 EFFICIENT CHEST PAIN EVALUATION IN THE ED: ADDITIONAL VALUE OF HIGH SENSITIVITY TROPONIN (Invited Lecture)
J.H. Chesebro, UMASS Memorial Medical School and Medical Center, Worcester, MA, USA
183
09:15 ROBOTIC ASSISTED PCI: RESULTS OF THE PRECISE TRIAL USING THE CORPATH, REMOTE DELIVERY SYSTEM (Invited Lecture)
G.W. Vetrovec, VCU Pauley Heart Center, Richmond, VA, USA
184
09:30 FILLING IN THE GAPS IN THE TREATMENT OF LEFT MAIN DISEASE (Invited Lecture)
B. Uretsky, University of Arkansas, Little Rock, AR, USA
185
09:45 ATHEROSCLEROSIS AS A CAUSE OF VERY LATE STENT THROMBOSIS (Invited Lecture)
Y. Ueda
, Osaka Police Hospital, Tennoj-ku, Osaka, Japan
186
10:00 EMBOLIC PROTECTION IN STEMI: WHEN AND HOW? (Invited Lecture)
E. Kaluski, NJ Medical School & University Hospital, Newark, NJ, USA
188
10:15 A NOVEL APPLICATION OF EXERCISE TREADMILL TESTING IN A CARDIOLOGY PRACTICE (Invited Lecture)
Y. Charuzi, UCLA School of Medicine, Los Angeles, CA, USA
189
10:30 OUTCOMES OF ANTI-PLATELET THERAPY DIRECTED BY POST PCI PLATELET FUNCTION TESTING IN A REAL WORLD SETTING
E. Asher, M. Mayuga, M. Bradley, P. Anarado, G. Stefano, D.I. Simon, T. Lassar Harrington Heart & Vascular Institute, Case Medical Center, University Hospitals, Cleveland, OH, USA
190
10:45 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2012
08:30-11:00   HALL B

 

PL08   Plenary Session:
PLATELETS AND INFLAMMATION IN ISCHEMIC HEART DISEASE

Chairs:
L.C. Becker, Baltimore, MD, USA
J.G. Filep, Montreal, QC, Canada

 

08:30 C-REACTIVE PROTEIN AND CORONARY VASOMOTOR REGULATION (Invited Lecture)
L. Kuo, Texas A&M Health Science Center, Temple, TX, USA
191
08:45 CIGARETTE SMOKE INDUCES FRACTALKINE-DEPENDENT MONONUCLEAR CELL ARREST TO THE ARTERIAL ENDOTHELIUM: POTENTIAL CONSEQUENCES IN COPD (Invited Lecture)
M.J. Sanz, Universidad de Valencia, Spain
 
192
09:00 PLATELET FUNCTION AND CLINICAL ISCHEMIC OUTCOMES (Invited Lecture)
L.C. Becker, Johns Hopkins University School of Medicine, Baltimore, MD, USA
 
193
09:15 C-REACTIVE PROTEIN-MEDIATED ENDOTHELIAL DYSFUNCTION AND ACUTE CORONARY ARTERY DISEASE (Invited Lecture)
J.G. Filep, University of Montreal, QC, Canada
194
09:30 MEASUREMENT AND MANIPULATION OF LOX-1 LIGAND LEVEL TO PREDICT AND TO PREVENT CVD (Invited Lecture)
T. Sawamura, National Cerebral and Cardiovascular Center, Osaka, Japan
195
09:45 CARBAMYLATION VERSUS OXIDATION OF LDL: COMPETITION, MECHANISMS AND ROLE IN CARDIOVASCULAR DISEASE (Invited Lecture)
A.G. Basnakian, University of Arkansas for Medical Sciences, Little Rock, AR, USA
196
10:00

SMALL INTESTINE APPEARS TO PLAY A MAJOR ROLE IN SYSTEMIC INFLAMMATION AND CARDIOVASCULAR COMPLICATIONS (Invited Lecture)
M. Navab, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

197
10:15 IMMUNIZATIONS AND ACUTE CORONARY SYNDROMES: IS THERE A ROLE? (Invited Lecture)
M. Zahid, University of Pittsburgh, Pittsburgh, PA, USA
198
10:30 CORONARY PLAQUE EROSION AND MYELOPEROXIDASE: INSIGHT FROM A CLINICOPATHOLOGICAL STUDY (Invited Lecture)
G. Niccoli
, Catholic University of the Sacred Heart, Rome, Italy
199
10:45 DEFINING THE ANTI-INFLAMMATORY ACTIVITY OF M-T7, A MYXOMAVIRAL CHEMOKINE MODULATOR THROUGH MUTAGENESIS
M.Y. Bartee, H. Chen, E. Dai, L. Liu, J.A. Davids, A.R. Lucas, University of Florida, Gainesville, FL, USA
200
11:00 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2012
08:30 - 10:45   HALL C
  S26   Session:  
NEW DIAGNOSTIC METHODS AND IMAGING TECHNIQUES / ECHOCARDIOGRAPHY

Chairs:
T. Akasaka, Wakayama, Japan
N.J. Angomachalelis, Thessaloniki, Greece
 
08:30 ACCURATE, NONINVASIVE DIAGNOSIS OF CARDIOGENIC SHOCK BASED ON ECHOCARDIOGRAPHY RATHER THAN INVASIVE HEMODYNAMIC ASSESSMENT
A. Najafi
, K. Ghafourian, A. Paixao, M. Aljaabari, M. Iantorno, J. Panza, F. Asch, H Cooper, Washington Hospital Center, Washington, DC, USA
201
08:45 PAIRED PACING IDENTIFIES VIABLE LEFT VENTRICULAR SEGMENTS WITHOUT CONTRACTILE RESPONSE TO DOBUTAMINE IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
M. Chandra, J.A. Strom, J. Shirani, St. Luke's University Health Network, Bethlehem, PA, USA
202
09:00 DOPPLER ECHOCARDIOGRAM UNDERESTIMATES PULMONARY ARTERY PRESSURE IN PATIENTS WITH INSUFFICIENT TRICUSPID REGURGITANT JET
M. Aldeiri
, A. Khanfar, P. Nalabothu, M. Morsy, W.I. Khalife, University of Texas Medical Branch, Galveston, TX, USA
203
09:15 NOVEL TISSUE DOPPLER PARAMETERS IN STAGING OF DIASTOLIC DYSFUNCTION
N. Nair, S. John, D. Jupiter, E. Gongora, P. Lammert, C. Tong, TAMHSC College of Medicine, Temple, TX, USA
204
09:30 ECHO AND TISULAR DOPPLER ASSESSMENT OF SYSTOLIC AND DIASTOLIC FUNCTION IN SCLERODERMA
C.S. Berensztein, A.K. Saad, O. Grosso, E. Bresan, H. Laborde, M. Vazquez, Blanco Hospital de Clinicas, Universidad de Buenos Aires, Buenos Aires, Argentina
205
09:45 ROLE OF MITRAL INFLOW AND TISSUE DOPPLER IMAGING IN DETECTING MYOCARDIAL VIABILITY BY DOBUTAMINE STRESS ECHOCARDIOGRAPHY
O.A. Rifaie
, Z.F. Abdelsalam, M.A. Abdallah, H.A. Ismail, AinShams University Cairo, Egypt
206
10:00 LEFT ATRIAL FUNCTION IN IDIOPATHIC PULMONARY HYPERTENSION
M. Henein, G. Bajraktari, S. Soderberg, M. Y Henein, P. Lindqvist, Umea University, Umea, Sweden
207
10:15 DIAGNOSTIC UTILITY OF TRANSTHORACIC ECHOCARDIOGRAPHY IN EVALUATION OF PEDAL EDEMA
J. Kahan
, F. Bajwa, H. Makani, A. Supariwala, A. Shah, N. Htyte, F. Chaudhry, St. Luke's Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, NY, USA
486
10:30 CHARACTERIZING DIFFERENCES IN ECHOCARDIOGRAPHIC PARAMETERS OF DIASTOLIC FUNCTION BETWEEN ATRIAL FIBRILLATION AND SINUS RHYTHM AMONG PATIENTS WITH HFPEF IN A REAL WORLD COHORT
M.S. Sidhu, A.M. Robert, J.R. Brown, J.N. Gigliotti, J. Zipursky, S.P. Costa, R.T. Palac, D.J. Malenka, M.L. Greenberg, A.T. Kono, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
208
10:45 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2012
08:30 - 10:30   HALL D
  S27   Session:  
HYPERTENSION, BASIC AND CLINICAL

Chairs:
C. Desouza, Boulder, CO, USA
 
08:30 INFLUENCE OF SLEEP-TIME BLOOD PRESSURE IN THE PROGNOSTIC VALUE OF ISOLATED-OFFICE AND MASKED HYPERTENSION
R.C. Hermida, D.E. Ayala, A. Mojon, J.R. Fernandez, University of Vigo, Vigo, Spain
209
08:45 ROLE OF TIME-OF-DAY OF HYPERTENSION TREATMENT ON THE J-SHAPED RELATIONSHIP BETWEEN BLOOD PRESSURE AND CARDIOVASCULAR RISK
R.C. Hermida, D.E. Ayala, A. Mojon, J.R. Fernandez University of Vigo, Vigo, Spain
210
09:00 AMBULATORY BLOOD PRESSURE PATTERN OF RESISTANT HYPERTENSION: DEPENDENCE ON TREATMENT-TIME REGIMEN OF HYPERTENSION MEDICATIONS: THE HYGIA PROJECT
M.T. Rios, J.J. Crespo, M. Dominguez, J. Boveda, C. Duran, A. Ferreras, A. Otero, M.J. Fontao, D.E. Ayala, R.C. Hermida, University of Vigo, Vigo, Spain
211
09:15 EFFECTS OF VALSARTAN, EPROSARTAN OR LOSARTAN ON DIASTOLIC FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION
L. Popescu, A. Caraush, Institute of Cardiology, Republic of Moldova
212
09:30 EFFECTS OF HYPERTENSION TREATMENT-TIME ON AMBULATORY BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE: THE HYGIA PROJECT
D.E. Ayala
, L. Pineiro, A. Moya, J.J. Crespo, A. Otero, E. Sineiro, S. Hernaiz, E. Marquez, A. Mojon, R.C. Hermida University of Vigo, Vigo, Spain
213
09:45 BLOOD PRESSURE PROFILE IN A STUDENT POPULATION FROM THE METROPOLITAN AREA OF CAMPINAS, BRAZIL
D.J.B. Saraiva, A. Timerman, J.F.K. Saraiva, A. Avezum, J.R.Z. Mendes Sao Paulo State Cardiology Society, Sao Paulo, SP, Brazil
 
214
10:00 INTER-ARM SYSTOLIC BLOOD PRESSURE DIFFERENCE OF 15MM HG OR MORE IN TREATED HYPERTENSIVES
N.K. Agarwal, S.K. Agarwal, Agarwal Health Center, East Orange, NJ, USA
 
215
10:15 ADVERSE IMPACT OF HYPERTENSION ON MORTALITY IN ELDERLY WOMEN AND MEN PRESENTING WITH ACUTE MYOCARDIAL INFARCTION
V.N. Singh, N.N. Singh, J. Levine, N.N. Singh, M. Nelson, L. Marlow University of South Florida College of Medicine, Tampa, FL, USA
 
216
10:30 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
11:15-14:00   HALL A
 

PL09    Plenary Session:
VALVULAR AND CONGENITAL HEART DISEASE
Joint Session with the Heart Valve Society of America
 

Chairs:
W.J. Bommer, California, CA, USA
J.S. Borer
, New York, NY, USA

 
11:15 THE ROLE OF LRP5 IN CALCIFIC AORTIC VALVE DISEASE: LDL-DENSITY-PRESSURE THEORY (Invited Lecture)
N. Rajamannan, Mayo Clinic, Rochester, MN, USA
217
11:30 THE IMPACT OF HYPERTENSION AND ITS TREATMENT IN HEART VALVE DISEASE (Invited Lecture)
J .S. Borer
, State University of New York Downstate Medical Center, New York, NY, USA
218
11:45 PCI AND TAVR PERFORMANCE MEASURES: ONSITE VERSUS OFFSITE MONITORING (Invited Lecture)
W.J. Bommer, University of California Davis, Medical Center, CA, USA
219
12:00 INTERVENTION IN ADULT CONGENITAL HEART DISEASE – STENTING IN COARCTATION OF THE AORTA WITH SPECIAL REFERENCE TO THE ROLE OF COVERED STENTS (Invited Lecture)
M. Sadiq, Punjab Institute of Cardiology, Lahore, Pakistan
220
12:15 ADVANCES IN MANAGEMENT OF VALVULAR HEART DISEASE IN THE ELDERLY (Invited Lecture)
I. Mikati, Northwestern Memorial Hospital, Chicago, IL, USA
221
12:30 PROSTHETIC VALVE THROMBOSIS: UNDERSTANDING THE GUIDELINES (Invited Lecture)
S. Pislaru
, Mayo Clinic College of Medicine, Rochester, MN, USA
222
12:45 SPECKLE TRACKING ECHOCARDIOGRAPHY PREDICTS OUTCOMES IN CHRONIC AORTIC REGURGITATION (Invited Lecture)
N.T. Olsen
, Roskilde Hospital, Denmark
223
13:00 ANTICOAGULATION IN PREGNANT WOMEN WITH POSTHETIC VALVES (Invited Lecture)
S. Goland, Kaplan Hospital, Rehovot, Israel
224
13:15 A LUMPED-PARAMETER MODEL OF MITRAL VALVE BLOOD FLOW FOR ASSESSMENT OF DIASTOLIC LEFT VENTRICULAR FILLING
G. Szabo, J. Fine, G. Veres, M. Karck, L. Waite, University of Heidelberg, Heidelberg, Germany
225
13:30 ARE PATENT FORAMEN OVALE INHERITED? A MONOZYGOTIC TWIN STUDY
R. Gurtu, S.G. Ray, W. Newman, F. MK Williams, C.N. McCollum, Manchester Health Academic Sciences Centre, University of Manchester, Manchester, UK
 
226
13:45 CLINICAL AND ECHOCARDIOGRAPHIC PROFILE AND PREGNANCY OUTCOMES IN PATIENTS WITH RHEUMATIC HEART DISEASE AT THE UNIVERSITY OF THE PHILIPPINES-PHILIPPINE GENERAL HOSPITAL
M.J.T. Reyes
, L. Macapugay, K. Tumabiene, M. Alferez, F.R. Punzalan, UP-Philippine General Hospital, Manila, Philippines
227
14:00 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2012
11:15-13:45   HALL B

 

PL10   Plenary Session:
ATRIAL FIBRILLATION – NEW RISK FACTORS AND THERAPIES

Chairs:
A. Bollmann, Leipzig, Germany
A. Martinez-Rubio, Barcelona, Spain

 

11:15 METABOLIC SYNDROME AND DYSLIPIDEMIA AS RISK FACTORS FOR ATRIAL FIBRILLATION (Invited Lecture)
H. Watanabe, Niigata University Graduate School of Medical & Dental, Japan
228
11:30 GENOTYPE-BASED ATRIAL FIBRILLATION THERAPIES (Invited Lecture)
D. Husser, Heart Center Leipzig, Germany
229
11:45 CRYOABLATION OF ATRIAL FIBRILLATION: IS IT READY FOR PRIMETIME? (Invited Lecture)
K. Srivathsan, Mayo Clinic Arizona, Phoenix, AZ, USA
230
12:00 ANTICOAGULATION AND ATRIAL FIBRILLATION: ANTITHROMBOTICS STATE OF THE ART (Invited Lecture)
K. Seidl
, Klinikum Ingolstadt, Ingolstadt, Germany
231
12:15 NOVEL TECHNOLOGIES FOR ATRIAL FIBRILLATION MONITORING AND CATHETER ABLATION (Invited Lecture)
A. Bollmann, D. Husser, Heart Center, Leipzig, Germany
232
12:30 NEW ANTICOAGULANTS IN ATRIAL FIBRILLATION: ARE ALL THE SAME? (Invited Lecture)
A. Martinez-Rubio, Hospital de Sabadell, Barcelona, Spain
233
12:45 ATRIAL FIBRILLATION ABLATION USING ANATOMICALLY DESIGNED CATHETERS AND UNDER DIRECT VISION (Invited Lecture)
T. Deneke, A. Schade, Heart Center Bad Neustadt, Bad Neustadt, Germany
234
13:00 DISMAL RATES OF ANTICOAGULATION IN ELDERLY WOMEN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
V.N. Singh, N.N. Singh, J. Levine, N.N. Singh, M. Nelson, L. Marlow University of South Florida College of Medicine, Tampa, FL, USA
235
13:15 LONG TERM OUTCOME OF ATRIAL FIBRILLATION THERAPIES: AN ACAP-RACE REGISTRY ANALYSIS
E.F. Aziz, B. Pratap, C.K. Pamidimukala, T. Park, S. Qadir, H. Muafa, P. Gnanaprakasam, R. Reddy, U. Pai, E. Herzog, St. Luke's-Roosevelt Hospital Center, University Hospital Columbia University, College of Physicians and Surgeons, New York, NY, USA
 
236
13:30 RENIN-ANGIOTENSIN SYSTEM GENE POLYMORPHISMS AND THE RISK OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE OBSERVATION STUDY
C-T. Tsai, J.L. Lin, J.J. Hwang, L.P. Lai, National Taiwan University Hospital, Taipei, Taiwan
 
237
13:45 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2012
11:15 - 13:15   HALL C
  S28   Session:  
RECENT ADVANCES IN CARDIAC IMAGING / RISK PREDICTION

Chairs:
M-R. Movahed, Tucson, AZ, USA
T. Tomaru, Chiba, Japan
 
11:15 ASSESSMENT OF VIABILITY IN PATIENTS WITH CHRONIC TOTAL OCCLUSIONS: A CARDIAC MAGNETIC RESONANCE STUDY
D.J. Shah, H.W. Kim, R.J. Kim, Methodist Debakey Heart & Vascular Center, Houston, TX and Duke Cardiovascular Magnetic Resonance Center, Durham, NC, USA
238
11:30 CORKSCREW CORONARY ARTERIES: INNOCENT BYSTANDER OR SIGNIFICANT RISK FACTOR?
D. Godkar, N. Gupta, S. Jain, A. Hamdan, V. De Bari, F. Shamoon, M. Bikkina Seton Hall University, Newark, NJ, USA
239
11:45 ANATOMY OF MAIN CORONARY ARTERY LOCATION: RADIAL POSITION AROUND THE AORTIC ROOT CIRCUMFERENCE
Z. Almuwaqqat, M. Tranquilli, J.A. Elefterides, Yale University, New Haven, CT, USA
240
12:00 A PATH TO SAFE MRI SCANNING OF CARDIAC PACEMAKER PATIENTS: A ROLE FOR COMPUTER MODELING
S-M. Park, M. Lazebnik, J.J. Hunt, S.J. Fraasch, J.H. Harrison, Medtronic, Inc., Mounds View, MN, USA
241
12:15 MYOCARDIAL PERFUSION IMAGING IN PATIENTS WITH ATRIAL FIBRILLATION IS NOT INFERIOR TO REGULAR SINUS RHYTHM FOR SCREENING OF CORONARY ARTERY DISEASE
S. Her, M.W. Park, C.J. Kim, Daejeon St. Mary's Hospital, Daejeon, South Korea
242
12:30 VALIDATION OF SPECKLE TRACKING STRAIN MEASUREMENTS AS AN ACCURATE AND REPRODUCIBLE TECHNIQUE FOR DETECTING GLOBAL AND SEGMENTAL MYOCARDIAL DEFORMATION
A.M. Anwar, Y.F. Nosir, M. Alasnig, M.A. Llemit, A.F. Elhagoly, H. Chamsi-Pasha, King Fahd Armed Force Hospital, Jeddah, Saudi Arabia
243
12:45 LEFT ATRIAL SYSTOLIC STRAIN RATE ESTIMATES PULMONARY CAPILLARY PRESSURE: A SIMULTANEOUS ECHOCARDIOGRAPHY AND CARDIAC CATHETERIZATION STUDY
M. Henein, S. Soderberg, M. Gonzalez, E. Tossavainen, M.Y. Henein, P. Lindqvist Umea University, Umea, Sweden
244
13:00 THE CLINICAL IMPLICATIONS OF A NORMAL CORONARY CT ANGIOGRAM
J.N. Makaryus, P. Ruisi, A.N. Makaryus, S. Desai, North Shore University Hospital, Manhasset, New York, NY, USA
245
13:15 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2012
11:15 - 13:15   HALL D
  S29   Session:  
VASCULAR BIOLOGY, BASIC RESEARCH

Chairs:
N.G. Frangogiannis, Bronx, NY, USA
S-J. Lin, Taipei, Taiwan
 
11:15 CHRONIC STRESS CONVERTS ATHEROSCLEROTIC LESIONS FROM A STABLE TO A MORE VULNERABLE PHENOTYPE A.H. Najafi, N. Aghili, J.U. Tilan, J.A. Andrews, X. Peng, R. Virmani, Z. Zukowska, S.E. Epstein, M.S. Burnett, Cardiovascular Research Institute, Washington, DC, USA 246
11:30 CYSTATHIONINE-GAMMA-LYASE: A NOVEL THERAPEUTIC TARGET IN TREATING SEPTIC SHOCK
G. Sikka, A.K. Mustafa, J. Steppan, S.M. Jung, L. Santhanam, V. Barodka, J. Sevilla, D. Nyhan, S.H. Snyder, D.E. Berkowitz Yale School of Medicine, New Haven, CT, USA
247
11:45 INCREASED ANGIOGENESIS IS NOT ABLE TO IMPROVE HEART FUNCTION AFTER CELL THERAPY
A. Schuh, A. Curaj, S. Konschalla, A. Kroh, B. Butzbach, A. Schober, E. Liehn, RWTH Aachen University, Aachen, Germany
248
12:00 INFLUENCE OF CONTRAST MEDIUM ON THE ENDOTHELIAL CELL LINE HCMEC
A. Peleg, Y. Hasin, Poriya, Cardiovascular Research Lab, Tiberias, Israel
 
249
12:15 ESSENTIAL ROLE OF ROS IN MEDIATING STRETCH-INDUCED LEPTIN SECRETION AND VASCULAR SMOOTH MUSCLE HYPERTROPHY
C. Ghantous, L. Dib, M. Al-Hariri, A. Jaffa, A. Zeidan, American University of Beirut, Lebanon
 
250
12:30 THE OMEGA 3 EPA:DHA 6:1 CAUSES REDOX-SENSITIVE PI3-KINASE/AKT- DEPENDENT ACTIVATION OF ENDOTHELIAL NO SYNTHASE
F. Zgheel, M. Alhosin, C. Auger, V.B. Schini-Kerth, Strasbourg University, Illkirch, France
 
251
12:45 INTRAVENOUS COCAINE ADMINISTRATION RESULTS IN TRANSIENT DECREASE IN SERUM LEVELS OF INTERLEUKIN-6 (IL-6), SOLUBLE CD40 LIGAND (SCD40L) AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1)
R. Sharma, K.N. Dileepan, K. Grasing, B. Dawn, K. Gupta, Kansas City VA Medical Center, Kansas City, MO, USA
 
252
13:00 ORAL ANTI INFLAMMATORY PEPTIDE F REDUCES SYSTEMIC INFLAMMATION AND IMPROVES HDL FUNCTION
A. Gapele, O. Elboudwarej, J. Bowers Obioha, S. Vazirian,
M. Memarzadeh, G. Hough, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
 
253
13:15 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2012
14:00 - 16:30   HALL A
 

PL11   Plenary Session:
PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE – RISK FACTORS AND PREVENTION

Chairs:
U. Keil, Muenster, Germany
J.L. Mehta
, Little Rock, AR, USA

 
14:00 CARDIOVASCULAR PREVENTION - A GLOBAL PROBLEM (Invited Lecture)
U. Keil
, University of Muenster, Germany
 
288
14:15 DIURNAL RHYTHMS AND THE PATHOGENESIS OF CARDIOVASCULAR DISEASE (Invited Lecture)
M.J. Sole, University of Toronto, Toronto, ON, USA
289
14:30 RECONSIDERATION OF THE ROLE OF STATINS IN PRIMARY PREVENTION; POTENTIAL OF ADVERSE EFFECT RELATED TO GENETIC VARIABILITY (Invited Lecture)
J.L. Mehta, UAMS, Little Rock, AR, USA
290
14:45 COFFEE DRINKING AND RISK OF STROKE (Invited Lecture)
A.L. Klatsky, Kaiser Permanente Medical Center, Oakland, CA, USA
291
15:00 ACUTE RESPIRATORY INFECTIONS AS TRIGGERS FOR CARDIOVASCULAR EVENTS (Invited Lecture)
M. Madjid
, Texas Heart Institute, Houston, TX, USA
292
15:15 STATINS FOR THE PRIMARY PREVENTION OF CVD IN WOMEN (Invited Lecture)
S. Mora, Brigham and Women's Hospital, Boston, MA, USA
293
15:30 LIFESTYLE FACTORS AND THE RISK OF STROKE (Invited Lecture)
G. Hu, Pennington Biomedical Research Center, Baton Rouge, LA, USA
294
15:45 DIET AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE: THE CURRENT LEVEL OF EVIDENCE (Invited Lecture)
D.B. Panagiotakos, Harokopio University of Athens, Greece
295
16:00 FROM SURROGATE BIOMARKERS TO DETECTION OF ATHEROSCLEROSIS: ARE WE READY FOR A PARADIGM SHIFT IN PRIMARY CVD PREVENTION STRATEGIES? (Invited Lecture)
K. Nasir, Yale University, New Haven, CT, USA
296
16:15 NOVEL PROBIOTIC FORMULATION FOR MANAGING CHOLESTEROL: CLINICAL INVESTIGATION OF BSH-ACTIVE LACTOBACILLUS REUTERI NCIMB 30242 YOGURT AND CAPSULE FORMULATIONS IN HYPERCHOLESTEROLEMIC ADULTS
M.L. Jones, C.J. Martoni, S. Prakash McGill University, and Micropharma, Montreal, Quebec, Canada
298
16:30 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 29, 2012
14:00 - 16:30   HALL B
  PL12   Plenary Session:
PATHOGENESIS, DIAGNOSIS AND TREATMENT OF AORTIC ANEURYSMS AND PERIPHERAL ARTERY DISEASE

Chairs:
J.A. Elefteriades, New Haven, CT, USA
S.D. Gertz
, Jerusalem, Israel
 
14:00

ACUTE AORTIC DISEASES: TEMPORAL PATTERNS OF ONSET AND CLINICAL OUTCOME (Invited Lecture)
R. Manfredini
, University of Ferrara, Italy
 

300
14:15 THERE IS AN EFFECTIVE MEDICAL TREATMENT FOR THORACICAORTIC ANEURYSM (Invited Lecture)
J.A. Elefteriades, Yale University School of Medicine, New Haven, CT, USA
299
14:30 CORONARY, CEREBRAL, AND ABDOMINAL AORTIC ANEURYSMS: SIMILARITIES IN PATHOGENESIS AND IMPLICATIONS FOR TREATMENT (Invited Lecture)
S.D. Gertz, L.Y. Gavish, R. Beeri, D. Gilon, C. Rubinstein, Y. Berlatzky, A. Bulut, M. Harlev, P. Reissman, L. Gavish, The Hebrew University, Hadassah Faculty of Medicine, Jerusalem, Israel
301
14:45

PREDICTION OF PROGNOSIS BY VACULAR IMAGINGS IN PERIPHERAL ARTERY DISEASE AFTER ENDOVASCULAR TREATMENT (Invited Lecture)
T. Tomaru
, Toho University Sakura Hospital, Japan

302
15:00 ROLE OF IgE IN ANGIOTENSIN II-INDUCED ABDOMINAL AORTIC ANEURYSMS IN APOLIPOPROTEIN E-DEFICIENT MICE (Invited Lecture)
G-P. Shi, Brigham and Women's Hospital, Boston, MA, USA
303
15:15 CRYOPLASTY OR CONVENTIONAL BALLOON POST-DILATION OF NITINOL STENTS FOR REVASCULARIZATION OF PERIPHERAL ARTERIAL SEGMENTS (COBRA TRIAL) (Invited Lecture)
S. Banerjee, D. Tran, E.S. Brilakis, VA North Texas Healthcare System, Dallas, TX, USA
304
15:30

DA VINCI ROBOT AND VASCULAR SURGERY
P. Stadler
, L. Dvoracek, P. Vitasek, P. Matous, Na Homolce Hospital, Prague, Czech Republic

305
15:45 INTRALUMINAL VERSUS SUBINTIMAL APPROACH TO CHRONIC TOTAL OCCLUSIONS IN PERIPHERAL ARTERIAL DISEASE
S. Amruthlal Jain, T. Larsen, F. Alcocer, M. Zughaib, P. Alexander, Providence Hospital and Medical Center, Southfield, MI, USA
306
16:00 A SIMPLE, FAST AND ACCURATE METHOD TO DETECT PERIPHERAL ARTERIAL DISEASE IN AN OFFICE SETTING
H.J. Semler, G.L. Geary, R. McRae, N. Santos Oregon Health Science University, Portland, OR, USA
307
16:15 CAROTID INTIMA MEDIA THICKNESS PROVIDES EVIDENCE THAT ASCENDING AORTIC ANEURYSM PROTECTS AGAINST SYSTEMIC ATHEROSCLEROSIS
A. Hung, M. Zafar, S. Mukherjee, M. Tranquilli, L. Scoutt, J.A. Elefteriades Yale University School of Medicine, New Haven, CT, USA
308
16:30 COFFEE BREAK, VISIT POSTERS & EXHIBITION
SUNDAY, JULY 29, 2012
14:00 - 16:30   HALL C
  S30  Session:
ARRHYTHMIA I: SUDDEN CARDIAC DEATH / ADVANCES IN IMPLANTABLE RHYTHM THERAPY

Chair:
K. Seidl, Ingolstadt, Germany
M. Takagi, Osaka, Japan

 
14:00 DOES PHYSICIAN REVIEW IMPROVE THE ACCURACY OF NATIONAL CARDIOVASCULAR DATA REGISTRY (NCDR) ICD REGISTRY DATA SUBMISSION? THE WAKE FOREST BAPTIST MEDICAL CENTER (WFBMC) EXPERIENCE
M. Jain, N. Shah, R. Henderson, B. Rubery, G. Brammer,
T. Simmons, Wake Forest Baptist Medical Center, Winston Salem, NC, USA
309
14:15 RESULTS OF THE LEAD EXTRACTION DEVICE EVALUATION AND RESULTS (LEADER) DATABASE
C.J. Love, S.P. Kutalek, C. Starck, E.K. Bowser,
B.E. Norlander, The Ohio State University, Columbus, OH, USA
310
14:30 PACEMAKERS IN PATIENTS WITH HIGH SPINAL INJURY
B.R. Porter, H. Jayanthi, A. Money-Kyrle, Buckinghamshire Healthcare Trust, Stoke Mandeville Hospital, Bucks, UK
311
14:45 USE AND LONG-TERM OUTCOMES OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEVICES IN A POPULATION STUDY
P.J. Bradshaw, M.S.T. Hobbs, T.G. Briffa, University of Western Australia, Perth, WA, Australia
 

312
15:00 USING PACEMAKER/IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MODE SWITCH QUANTIFICATION TO ASSESS CLINICAL PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE
P. Ruisi, J.N. Makaryus, J.N. Catanzaro, A. Cedrone,
A.N. Makaryus, R. Jadonath, S.J. Belner, S. Desai, North Shore University Hospital, Manhasset, NY, USA
313
15:15 COMMUNITY CARDIOVASCULAR SCREENING TO IDENTIFY MIDDLE SCHOOL CHILDREN AT RISK OF SUDDEN CARDIAC DEATH: THE HOUSTON EARLY AGE RISK TESTING AND SCREENING (HEARTS) STUDY
J.P. Higgins
, S.T. Laing, J.A. Samuels, A. Rajmane, G. Biliciler-Denktas, D.D. Mcpherson, A. Ali, The University of Texas Medical School at Houston, Houston, TX, USA
314
15:30 LONG-TERM SURVIVAL AND AICD THERAPY IN SURVIVORS OF CARDIAC ARREST TREATED WITH THERAPEUTIC HYPOTHERMIA
B. Saour, V. Khurana, J. Yong, T. Waters, M. Liakos, M. Torosoff, Albany Medical Center, Albany, NY, USA
315
15:45 CONTRACTILITY-GUIDED VENTRICULAR LEAD IMPLANT OPTIMIZES PACING AMONG PATIENTS WITH STRUCTURAL HEART DISEASE
P.P. Karpawich, K. Zelin, H. Singh, The Children's Hospital of Michigan, Wayne State University, Detroit, MI, USA
316
16:00 SYSTEMATIC ANALYSIS OF FAILED ATP IN AICD TO ACHIEVE RHYTHM IDENTIFICATION
J.C. Caldwell, D.P. Redfearn, A.M. Baranchuk, K.A. Michael, C. Simpson, H. Abdollah, Arrhythmia Service, Kingston General Hospital, Kingston, ON, Canada
317
16:15 MYOTONIC DYSTROPHY AND CARDIAC CONDUCTION SYSTEM ABNORMALITIES: HOW AWARENESS AFFECTS THE PATIENT OUTCOME?
K. Khalighi, S.B. Thapamagar, N. Singh, Easton Hospital, Easton, PA, USA, Drexel University, Philadelphia, PA, USA
318
16:30 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 29, 2012
14:00 - 16:15   HALL D
  S31  Session:
THE RELEVANCE OF GENETICS IN PROVIDING UNDERSTANDING AND TREATMENT FOR CARDIOVASCULAR DISEASES

Chairs:
J.D. Marsh, Little Rock, AR, USA
T. Toyo-Oka, Tokyo, Japan
 
14:00 INTERACTION BETWEEN TELOMERASE AND MYOCARDIN A CRITICAL FOR CARDIOMYOGENIC DEVELOPMENT OF MESENCHYMAL STEM CELLS: AN IMPLICATION FOR CARDIOVASCULAR TISSUE REPAIR AND REGENERATION
Y-J. Geng, University of Texas Houston Medical School, Houston, TX, USA
319
14:15 DETRIMENTAL IMPACT OF DIABETES ON EPHA2 KNOCKOUT MICE FOLLOWING MYOCARDIAL INFARCTION
M.A. Farooqui
, J. Virag, S. Kent, W. O'Neal, F. Faiz, J. Vuncannon, J Hodges, East Carolina University, Greenville, NC, USA
320
14:30 GENETIC VARIANTS REDUCING MTR GENE EXPRESSION INCREASE RISK OF CONGENITAL HEART DISEASE IN HAN CHINESE POPULATION
H.Y. Wang
, J.Y. Zhao, X.H. Gong, G.Y. Huang, B. Qiao, W.Y. Duan, H.B. Shen, L Jin, Fudan University, China
321
14:45 THE MOLECULAR BASIS OF AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA: ASSESSMENT IN A LARGE COHORT OF HYPERCHOLESTEROLEMIC CHILDREN
A. van der Graaf, H.J. Avis, D.M. Kusters, M.N. Vissers, B.A. Hutten, J.C. Defesche, S.W. Fouchier, F.A. Wijburg, J.J.P. Kastelein, A. Wiegman, Academic Medical Center, Amsterdam, The Netherlands
322
15:00 HISTOLOGICAL AND FUNCTIONAL ASSESSMENT OF HUMAN PLACENTAL STEM CELLS IN A MYOCARDIAL RAT INFARCTION
G. Makhoul, Y.T. Ma, M. Duong, R. Chiu, R. Cecere McGill University, Montreal, QC, Canada
323
15:15 APICAL HYPERTROPHIC CARDIOMYOPATHY WITH A RARE MYBPC3 GENE MUTATION VARIANT
P.T. Bhattacharya, T.A. Ahmad, M.A. Bataineh, Mercy Catholic Medical Center, Drexel University, Philadelphia, PA, USA
324
15:30 INFLAMMATION FOLLOWING MYOCARDIAL INFARCTION PLAYS AN IMPORTANT ROLE IN COLLAGEN SYNTHESIS AND CARDIAC REMODELLING
A. Curaj, S Simsekyilmaz, I. Kanzler, A. Schuh, E. Liehn, Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany
325
15:45 A MISSENSE MUTATION IN THE CHRM2 GENE IS ASSOCIATED WITH FAMILIAL DILATED CARDIOMYOPATHY
L. Zhang
, A. Hu, H. Yuan, L. Cui, G. Miao, X. Yang, L. Wang,
J. Liu, X. Liu, S. Wang Beijing Chao-Yang Hospital affiliated Capital Medical University, Beijing, China
326
16:00 GLUCOCORTICOID AMELIORATED EARLY CARDIAC DYSFUNCTION AFTER CORONARY MICROEMBOLIZATION BY SUPPRESSING TGF-BETA1/SMAD3 AND CTGF EXPRESSION
Z.W. Chen, J.Y. Qian, J.Y. Ma, S.F. Chang, Y.Z. Zou, J.B. Ge, Zhongshan Hospital, Fudan University, Shanghai, China
327
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 29, 2012
16:45-19:00   HALL A
  PL13   Plenary Session:
EMERGING MOLECULAR PARADIGMS IN MYOCARDIAL ISCHEMIA, INFARCTION AND REMODELING

Chairs:
L.A. Kirshenbaum, Winnipeg, MB, Canada
C.S. Long
, Denver, CO, USA
 
16:45 LINEAGE MARKERS IN TRACKING CARDIAC FIBROBLAST FATE IN VIVO AND IN VITRO (Invited Speaker)
C.S. Long, University of Colorado Health Sciences Center, Denver, CO, USA
328
17:00 p90RSK REGULATES CHIP UB LIGASE ACTIVITY VIA ERK5 AND PROMOTES CARDIAC DYSFUNCTION (Invited Speaker)
J-I. Abe
, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
329
17:15 NEGATIVE REGULATION OF TOLL LIKE RECEPTOR (TLR)/INTERLEUKIN-1 (IL-1) SIGNALING IN CARDIAC REPAIR (Invited Speaker)
N.G. Frangogiannis
, Albert Einstein College of Medicine, Bronx, NY, USA
330
17:30 CROSS-TALK BETWEEN MITOCHONDRIAL AND ER DEATH PATHWAYS IN THE HEART (Invited Speaker)
L.A. Kirshenbaum, University of Manitoba, Winnipeg, MB, Canada
331
17:45 STEM CELLS FOR CARDIAC REGENERATION IN THE DIABETIC AND NON-DIABETIC HEART (Invited Speaker)
D.K. Singla, University of Central Florida, Orlando, FL, USA
332
18:00 ROLE OF AUTOPHAGY IN THE HUMAN HEART EXPOSED TO IATROGENIC ISCHEMIA/REPERFUSION INJURY (Invited Speaker)
T.M. Scarabelli, Wayne State University School of Medicine, Detroit, MI, USA
333
18:15 HABITUAL SHORT SLEEP DURATION IS ASSOCIATED WITH ENDOTHELIAL FIBRINOLYTIC DYSFUNCTION
B.R. Weil, K.J. Diehl, J. Greiner, B.L. Stauffer, C.A. DeSouza, University of Colorado, Boulder, CO, USA
334
18:30 THE MOLECULAR MECHANISM OF GALECTIN-3-STIMULATED CARDIAC FIBROBLAST PROLIFERATION
W-R. Hao
, J.C. Liu, T.H. Cheng, J-J. Chen, Taipei Medical University, Taipei, Taiwan
335
18:45 MICRORNA-328 CONTRIBUTES TO ADVERSE REMODELING IN ATRIAL FIBRILLATION
Y.J. Lv, H.L. Shan, W.F. Chu, D-L. Dong, B.F. Yang, Harbin Medical University, Harbin, China
336
SUNDAY, JULY 29, 2012
16:45 - 18:45   HALL B
  PL14   Plenary Session:
HYPERTENSION: FROM GENETICS TO RECENT ADVANCES IN THERAPY

Chairs:
W.S. Aronow, Valhalla, NY, USA
E. Bossone, Amalfi Coast, Italy
 
16:45 ROLE OF ECHOCARDIOGRAPHY IN PULMONARY ARTERIAL HYPERTENSION: FROM DIAGNOSIS TO PROGNOSIS (Invited Speaker)
E. Bossone
, Cava de Tirreni & Amalfi Coast Hospital, Italy
337
17:00 HYPERTENSION IN ELDERLY (Invited Lecture)
W.S. Aronow
, Cardiology Division, New York Medical College, Valhalla, NY, USA
338
17:15 BLOOD PRESSURE TARGETS FOR PATIENTS WITH CORONARY ARTERY DISEASE: IS LOWER BETTER? (Invited Lecture)
C. Rosendorff, Mount Sinai School of Medicine, New York, NY and James J. Peters VA Medical Center, Bronx, NY, USA
339
17:30 SLEEP -TIME BLOOD PRESSURE AS A THERAPEUTIC TARGET FOR CARDIOVASCULAR RISK REDUCTION (Invited Lecture)
R.C. Hermida, Campus Universitario, Vigo, Spain
340
17:45 RENAL DENERVATION - STATE OF THE ART (Invited Lecture)
S.C. Bertog, Cardiovascular Center Frankfurt, Germany
341
18:00 PREHYPERTENSION: NOT A BENIGN VASCULAR CONDITION (Invited Lecture)
C. DeSouz
a, University of Colorado, Boulder, CO, USA
342
18:15 EMERGING MOLECULAR MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION: ARE WE CLOSER TO A CURE? (Invited Lecture)
D.J. Stewart, Ottawa Health Research Institute, The Ottawa Hospital, ON, Canada
343
18:30 HOW IMPORTANT IS WHITE-COAT HYPERTENSION FOR THE APPROPRIATE TREATMENT OF HIGH-RISK PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION? (Invited Lecture)
S.S. Franklin, University of California, Irvine, CA, USA
344
SUNDAY, JULY 29, 2012
16:45 - 19:15   HALL C
  S32  Session:
ARRHYTHMIA II: DIAGNOSIS, DRUG THERAPY, ABLATION

Chairs:
K.A. Adarsh, Amritsar, Punjab, India
A. Schade, Bad Neustadt, Germany
 
16:45 COMPARATIVE EFFICACY, COST AND RADIATION EXPOSURE DURING TACHYCARDIA ABLATION IN CHILDREN WITH AND WITHOUT FLUOROSCOPIC IMAGING
Y. Sanil, H. Singh, P.P. Karpawich, The Children's Hospital of Michigan, Wayne State University, Detroit, MI, USA
345
17:00 CHROMOSOME 4Q25 VARIANTS AND ATRIAL FIBRILLATION RECURRENCE AFTER CATHETER ABLATION
D. Husser, V. Adams, A. Arya, G. Hindricks, A. Bollmann, Heart Center Leipzig, Germany
346
17:15 NON-INVASIVE ASSESSMENT OF DRONEDARONE EFFECTS ON ATRIAL ELECTROPHYSIOLOGY DURING SINUS RHYTHM AND ATRIAL FIBRILLATION
S. John, J. Salmas, S. Lobe, M. Stridh, D. Husser, A. Bollmann, Heart Center Leipzig, Germany
347
17:30 DIMINISHED VALUE OF ADENOSINE REVEALING TRANSIENT PULMONARY VEIN CONDUCTION WHEN PRECEEDED BY RADIOFREQUENCY ABLATION GUIDED BY HIGH OUTPUT PACING INDUCED EXIT CONDUCTION
S.J. Pollak, G. Monir, Arrhythmia and Ablation Center, Florida Heart Institute, Orlando, FL, USA
348
17:45 PROGNOSTIC SIGNIFICANCE OF MINOR TROPONIN ELEVATION IN PATIENTS WITH NEW ONSET ATRIAL FIBRILLATION
S.K. Mathias, A.G. DeNazareth, J.A. Fernandes, P. Gangi, A. Smer, V.M. Alla, D.J. Esterbrooks, Creighton University, Omaha, NE, USA
349
18:00 HYBRID APPROACH WITH RADIOFREQUENCY AND CRYOBALLOON ABLATION FOR PAROXYSMAL ATRIAL FIBRILLATION
M. Ahmed, J.S. Sussman, T.H. Mahoney, J.H. Curwin, R.F. Coyne, K. Quinlan, S.L. Winters, Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ, USA
350
18:15 INTRACARDIAC ECHOCARDIORAPHY DOES NOT INCREASE ABLATION PROCEDURE TIME
J.E. Banchs
, G.E. Smith, S.M. Samii, E.D. Penny-Peterson, D.L. Wolbrette, G.V. Naccarelli, M.D. Gonzalez, Penn State Hershey Heart & Vascular Institute, Hershey, PA, USA
351
18:30 EFFECT OF RADIOFREQUENCY CATHETER ABLATION ON ECHOCARDIOGRAPHIC PARAMETERS OF LEFT VENTRICULAR SYNCHRONY IN PATIENTS WITH PRE-EXCITATION DUE TO WOLFF-PARKINSON-WHITE SYNDROME
G.H. Davoodi, H. Ashraf, A, Kazemisaeid, S. Sadeghian, A. Vasheghani-Farahani, M. Sahebjam, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
352
18:45 RELATIONSHIP BETWEEN OBESITY AND COMPLICATIONS IN ATRIAL FIBRILLATION PATIENTS UNDERGOING CATHETER ABLATION
N. Sawaya, N. Abi Hatem, R. Sunna, S.L. Winters, T.H. Mahoney, R.F. Coyne, J.H. Curwin, J.S. Sussman, Morristown Medical Center, Morristown, NJ, USA
353
19:00 MANAGEMENT OF ATRIAL FIBRILLATION BY CANADIAN ELECTROPHYSIOLOGISTS AFTER DISCONTINUATION OF THE PALLAS STUDY
K. Mohajer, B. Fregeau, V. Garg, A. Skanes, C.S. Simpson, D.P. Redfearn, K.A. Michael, A. Baranchuk, Heart Rhythm Service, Kingston General Hospital, Queen’s University Kingston, ON, Canada
354


 


 

 

Affiliated with

 

    international academy of cardiology

Endorsed by